Literature DB >> 17591886

Global changes in optic nerve head gene expression after exposure to elevated intraocular pressure in a rat glaucoma model.

Elaine C Johnson1, Lijun Jia, William O Cepurna, Thomas A Doser, John C Morrison.   

Abstract

PURPOSE: In glaucoma, the optic nerve head (ONH) is the likely site of initial injury and elevated intraocular pressure (IOP) is the best-known risk factor. This study determines global gene expression changes in the pressure-injured ONH.
METHODS: Unilateral sustained IOP elevation (glaucoma, n = 46) or optic nerve transection (n = 10) was produced in rats. ONHs were removed, and the retrobulbar optic nerves were graded for degeneration. Gene expression in the glaucomatous ONH with extensive injury was compared with that in the fellow ONH (n = 6/group), by using cDNA microarrays. Data from 12 arrays were normalized, significant differences in gene expression determined, and significantly affected gene classes identified. For the remaining ONH, grouped by experimental condition and degree of injury, quantitative reverse transcriptase-PCR (qPCR) and ANOVA were used to compare selected message levels.
RESULTS: Microarray analysis identified more than 2000 significantly regulated genes. For 225 of these genes, the changes were greater than twofold. The most significantly affected gene classes were cell proliferation, immune response, lysosome, cytoskeleton, extracellular matrix, and ribosome. A 2.7-fold increase in ONH cellularity confirmed glaucoma model cell proliferation. By qPCR, increases in levels of periostin, collagen VI, and transforming growth factor beta1 were linearly correlated to the degree of IOP-induced injury. For cyclinD1, fibulin 2, tenascin C, TIMP1, and aquaporin-4, correlations were significantly nonlinear, displaying maximum change with focal injury.
CONCLUSIONS: In the ONH, pressure-induced injury results in cell proliferation and dramatically altered gene expression. For specific genes, expression levels were most altered by focal injury, suggesting that further array studies may identify initial, and potentially injurious, altered processes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17591886      PMCID: PMC1950563          DOI: 10.1167/iovs.06-1282

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  109 in total

1.  Periostin and periostin-like factor in the human heart: possible therapeutic targets.

Authors:  Judith Litvin; Andrew Blagg; Anbin Mu; Sunil Matiwala; Michael Montgomery; Remus Berretta; Steven Houser; Kenneth Margulies
Journal:  Cardiovasc Pathol       Date:  2006 Jan-Feb       Impact factor: 2.185

2.  Influence of cyclical mechanical strain on extracellular matrix gene expression in human lamina cribrosa cells in vitro.

Authors:  Ruaidhrí P Kirwan; Cecilia H Fenerty; John Crean; Robert J Wordinger; Abbot F Clark; Colm J O'Brien
Journal:  Mol Vis       Date:  2005-09-23       Impact factor: 2.367

3.  Osteonectin is a Schwann cell-secreted factor that promotes retinal ganglion cell survival and process outgrowth.

Authors:  Edward T W Bampton; Chi Him Ma; Aviva M Tolkovsky; Jeremy S H Taylor
Journal:  Eur J Neurosci       Date:  2005-05       Impact factor: 3.386

Review 4.  Emerging roles for TGF-beta1 in nervous system development.

Authors:  Flávia Carvalho Alcantara Gomes; Vivian de Oliveira Sousa; Luciana Romão
Journal:  Int J Dev Neurosci       Date:  2005-08       Impact factor: 2.457

5.  Cell proliferation and replacement following contusive spinal cord injury.

Authors:  Laila J Zai; Jean R Wrathall
Journal:  Glia       Date:  2005-05       Impact factor: 7.452

6.  Transforming growth factor-beta1 is a negative modulator of adult neurogenesis.

Authors:  Frank-Peter Wachs; Beate Winner; Sebastien Couillard-Despres; Thorsten Schiller; Robert Aigner; Jürgen Winkler; Ulrich Bogdahn; Ludwig Aigner
Journal:  J Neuropathol Exp Neurol       Date:  2006-04       Impact factor: 3.685

7.  Connexin43, the major gap junction protein of astrocytes, is down-regulated in inflamed white matter in an animal model of multiple sclerosis.

Authors:  Elimor Brand-Schieber; Peter Werner; Dumitru A Iacobas; Sanda Iacobas; Michelle Beelitz; Stuart L Lowery; David C Spray; Eliana Scemes
Journal:  J Neurosci Res       Date:  2005-06-15       Impact factor: 4.164

8.  Transforming growth factor-beta-regulated gene transcription and protein expression in human GFAP-negative lamina cribrosa cells.

Authors:  Ruaidhrí P Kirwan; Martin O Leonard; Madeline Murphy; Abbot F Clark; Colm J O'Brien
Journal:  Glia       Date:  2005-12       Impact factor: 7.452

9.  The number of people with glaucoma worldwide in 2010 and 2020.

Authors:  H A Quigley; A T Broman
Journal:  Br J Ophthalmol       Date:  2006-03       Impact factor: 4.638

10.  Endogenous neurogenesis replaces oligodendrocytes and astrocytes after primate spinal cord injury.

Authors:  Hong Yang; Paul Lu; Heather M McKay; Tim Bernot; Hans Keirstead; Oswald Steward; Fred H Gage; V Reggie Edgerton; Mark H Tuszynski
Journal:  J Neurosci       Date:  2006-02-22       Impact factor: 6.167

View more
  126 in total

Review 1.  A biomechanical paradigm for axonal insult within the optic nerve head in aging and glaucoma.

Authors:  Claude F Burgoyne
Journal:  Exp Eye Res       Date:  2010-09-16       Impact factor: 3.467

2.  Expansions of the neurovascular scleral canal and contained optic nerve occur early in the hypertonic saline rat experimental glaucoma model.

Authors:  Marta Pazos; Hongli Yang; Stuart K Gardiner; William O Cepurna; Elaine C Johnson; John C Morrison; Claude F Burgoyne
Journal:  Exp Eye Res       Date:  2015-10-22       Impact factor: 3.467

Review 3.  Intrinsic axonal degeneration pathways are critical for glaucomatous damage.

Authors:  Gareth R Howell; Ileana Soto; Richard T Libby; Simon W M John
Journal:  Exp Neurol       Date:  2012-01-18       Impact factor: 5.330

4.  Involvement of EphB/Ephrin-B signaling in axonal survival in mouse experimental glaucoma.

Authors:  Christine T Fu; David Sretavan
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-01-05       Impact factor: 4.799

5.  Complement C3-Targeted Gene Therapy Restricts Onset and Progression of Neurodegeneration in Chronic Mouse Glaucoma.

Authors:  Alejandra Bosco; Sarah R Anderson; Kevin T Breen; Cesar O Romero; Michael R Steele; Vince A Chiodo; Sanford L Boye; William W Hauswirth; Stephen Tomlinson; Monica L Vetter
Journal:  Mol Ther       Date:  2018-08-24       Impact factor: 11.454

6.  Retinal cell responses to elevated intraocular pressure: a gene array comparison between the whole retina and retinal ganglion cell layer.

Authors:  Ying Guo; William O Cepurna; Jennifer A Dyck; Tom A Doser; Elaine C Johnson; John C Morrison
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-01-13       Impact factor: 4.799

Review 7.  Premise and prediction-how optic nerve head biomechanics underlies the susceptibility and clinical behavior of the aged optic nerve head.

Authors:  Claude F Burgoyne; J Crawford Downs
Journal:  J Glaucoma       Date:  2008 Jun-Jul       Impact factor: 2.503

Review 8.  Modeling glaucoma in rats by sclerosing aqueous outflow pathways to elevate intraocular pressure.

Authors:  John C Morrison; William O Cepurna; Elaine C Johnson
Journal:  Exp Eye Res       Date:  2015-05-21       Impact factor: 3.467

9.  Nuclear atrophy of retinal ganglion cells precedes the bax-dependent stage of apoptosis.

Authors:  Katherine T Janssen; Caitlin E Mac Nair; Joel A Dietz; Cassandra L Schlamp; Robert W Nickells
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-03-11       Impact factor: 4.799

Review 10.  Development of diagnostic and treatment strategies for glaucoma through understanding and modification of scleral and lamina cribrosa connective tissue.

Authors:  Harry A Quigley; Frances E Cone
Journal:  Cell Tissue Res       Date:  2013-03-28       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.